Cellectis (NASDAQ:CLLS) Shares Pass Below 200-Day Moving Average - Time to Sell?

Chart of the Day 📈 S&P 500 extends gains, supported by CTA fund buying

JPMorgan resets S&P 500 price target for the rest of 2026

Yesway prices IPO at $20 per share, to list on Nasdaq

Walmart Faces Antitrust Scrutiny While Expanding Healthcare And Supplier Programs

Driven Brands Faces Ongoing Filing Delays and Nasdaq Compliance Risks